摘要
目的:探讨非小细胞肺癌的病因,临床分期系统的改动及治疗方案进展。方法:通过翻译、收集、国内外对肺癌研究的病因、临床分期系统的改动及治疗方案的新进展文献资料,进行总结。结果:吸烟为肺癌的主要危险因素,氡气是226镭的衰变产物,有放射性,为肺癌的第二病因,遗传和基因的改变与肺癌关系密切。肺癌新分期系统的改动,提出了肺癌的综合治疗。结论:非小细胞肺癌遗传和基因是一种外因通过内因发病的因素,新的临床分期系统的改动,顺铂治疗方案为治疗晚期非小细胞肺癌的较好方案。
Objective： To explore the cause of nonsmall-cell lung cancer, change of clinical stage system and progress of treatment. Methods： The etiopathogenisis, change of clinical stage system and progress of treatment were analyzed by translating and collecting the data of the new progress of domestic and foreign study on nonsmall-cell lung cancer change. Results： Smoking was the primary hazard factor of lung cancer. Niton, the radioactivity product of 226 radium, was the second hazard factor. Heredity and the change of gene and were closely related with lung cancer. The change of clinical stage system was proposed and comprehensive therapy of the lung cancer was quite important. Conclusion： The heredity and the gene of the nonsmall-cell lung cancer were invasive factors in which the external factor worked through the internal, a new change of clinical stage system. Cis-platinum is better therapeutic plan for the later period of nonsmall-cellule lung cancer.
出处
《大理学院学报（综合版）》
CAS
2009年第6期76-79,共4页
Journal of Dali University
关键词
非小细胞肺癌
治疗
病因
分期改动
nonsmall-cell lung cancer
treatment
etiopathogenisis
change of stage
